Interpace Biosciences (STU:PF42) Accounts Payable & Accrued Expense : €10.47 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Interpace Biosciences Accounts Payable & Accrued Expense?

Interpace Biosciences's quarterly accounts payable & accrued expense declined from Dec. 2023 (€10.40 Mil) to Mar. 2024 (€9.61 Mil) but then increased from Mar. 2024 (€9.61 Mil) to Jun. 2024 (€10.47 Mil).

Interpace Biosciences's annual accounts payable & accrued expense declined from Dec. 2021 (€10.35 Mil) to Dec. 2022 (€9.77 Mil) but then increased from Dec. 2022 (€9.77 Mil) to Dec. 2023 (€10.40 Mil).

Interpace Biosciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Interpace Biosciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpace Biosciences Accounts Payable & Accrued Expense Chart

Interpace Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

13.11

13.32

10.35

9.77

10.40

Interpace Biosciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															9.94	10.36	10.40	9.61	10.47

Interpace Biosciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Interpace Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Interpace Biosciences Inc (STU:PF42) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IDXG:USA

Address

300 Interpace Parkway, Morris Corporate Center 1, Building C, Parsippany, NJ, USA, 07054

Website

https://www.interpace.com

Interpace Biosciences Inc is engaged in the life sciences industry. It provides molecular diagnostics, bioinformatics, and pathology services for the evaluation of the risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first-line assays principally focused on the early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology. It operates under one segment which is the business of developing and selling diagnostic clinical services.

Interpace Biosciences Headlines

No Headlines